Topline results from the chronic cohort of an ongoing phase 1b/2a clinical trial of an investigational therapeutic peptide, NVG-291, found the novel treatment led to increased electrical connectivity ...

Maharashtra AAR rules on K R Innovation's fruit protection bags, classifying them under HSN 48194000. Find out the impact on ...

Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such ...

Proton VPN stands out for two main reasons: it's one of the only virtual private networks (VPNs) to include a free plan with ...

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.

Here’s this week’s round-up of AI-powered martech releases and news.  CallMiner acquired VOCALLS, a platform that uses AI to manage voice, chat, messaging, and email interactions. CallMiner will ...

This research addresses the assessment of real options via the time-fractional Heston model, which takes into account jumps ...